Atlas Trials

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

Clinical trial NCT03310021 · COMPLETED

Trial details

NCT number
NCT03310021
Sponsor
Portola Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bleeding
Start date
2017-08-28
Primary completion
2019-08-13
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.